Investigation of menstrual disorders in systemic lupus erythematosus Patients
Preprint
- 10 October 2023
- preprint
- Published by Springer Nature in Research Square
Abstract
Background Persistent menstrual disorders are relatively common in patients with SLE, including hypermenorrhea, oligomenorrhea, amenorrhea, and temporary persistent amenorrhea. These failures are due to autoimmunity and medications, especially immunosuppressive agents. Materials and methods This cross-sectional pilot study was performed on all the SLE patients referred to our medical department who were eligible for participation. Venous blood samples were taken for FSH, LH, and anti-mullerian hormone measurement. Results 50 patients divided into two groups, 16–35 (46%) and 51 − 35 (54%), were included in the study. Among the patients, 82% used hydroxychloroquine, 80% prednisolone, 20% Azathioprine and 6% methotrexate. Dysmenorrhea was more common in the age group of 51 − 35 years, but there was no statistically significant difference between the two groups. The frequency of the people using prednisolone was remarkably more than non-users (94.7% vs. 5.3%), with a significant relationship between the two groups; However, there was no significant difference between patients with polymenorrhagia and menorrhagia. Additionally, menstrual disorders were not significant in patients who received hydroxychloroquine and azathioprine and those who received no medications. Furthermore, the frequency distribution of the mentioned menstrual disorders was investigated according to the SLEDAI index. The average FSH, LH, and anti-mullerian hormone values had no statistical difference between the mild, moderate, and severe flare groups. Conclusion In conclusion, menstrual cycle disorders with dysmenorrhea dominant are probably related to the drugs used, especially prednisolone, by patients with SLE.Keywords
All Related Versions
This publication has 12 references indexed in Scilit:
- Corticosteroids in LupusRheumatic Disease Clinics of North America, 2016
- Alterações menstruais em pacientes com lúpus eritematoso sistêmico sob uso de imunossupressoresRevista Brasileira de Reumatologia, 2010
- Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohortArthritis Care & Research, 2009
- Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L)Annals of the Rheumatic Diseases, 2007
- Reproductive and menopausal factors and risk of systemic lupus erythematosus in womenArthritis & Rheumatism, 2007
- Ethnic and geographical differences in systemic lupus erythematosus: an overviewLupus, 2006
- Pituitary hormones and systemic lupus erythematosusArthritis & Rheumatism, 2005
- Sex hormones and systemic lupus erythematosus: Review and meta‐analysisArthritis & Rheumatism, 2003
- Hyperprolactinemia in Systemic Lupus Erythematosus: Association with Disease ActivityThe American Journal of the Medical Sciences, 1992
- A Randomized Study of the Effect of Withdrawing Hydroxychloroquine Sulfate in Systemic Lupus ErythematosusNew England Journal of Medicine, 1991